Imaging is an ideal tool with which to evaluate response the aim of using imaging as a surrogate biomarker for therapeutic response in oncology is to obtain a measure of disease extent and to better understand tumor response earlier than is possible with other biomarkers or with primary endpoints when targeted therapy is available and can stabilize the disease patient survival or quality of . In my opinion imaging tumor response to therapy is an excellent book for all the medical professionals involved in oncology the book is well priced and is an important addition to anyone who is interested in the oncology field reviewed by khalid khashoggi md article history published online jan 2014 published in print jan 2014 figures references related details recommended . Who tumor response criteria and more recently recist response evaluation criteria in solid tumors have provided means to objectively measure tumor response in clinical trials with imaging these guidelines have been rapidly adopted in clinical practice to monitor patient treatment and for therapy planning however relying only on anatomical information is not always sufficient when . Multiparametric imaging of tumor response to therapy introduction to date the main focus for innovations in imaging has been the achievement of excellence in anatomic imaging depiction of tumor biology observations show us that cancers are complex evolving multiscale systems that are uses . Rationale early detection of tumor response to therapy is a key goal finding measurement algorithms capable of early detection of tumor response could individualize therapy treatment as well as reduce the cost of bringing new drugs to market on an individual basis the urgency arises from the desire to prevent continued treatment of the patient with a high cost and or high risk regimen with